The impact of the COVID-19 pandemic on the global burden of type 2 diabetes: a study based on GBD 2021 data
Open Access
- 15 October 2025
- journal article
- endocrinology
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1600333
Abstract
Background: This study aimed to comprehensively assess the impact of the coronavirus disease 2019 (COVID-19) pandemic on the global burden of type 2 diabetes mellitus (T2DM) using data from the Global Burden of Diseases (GBD) 2021.Methods: Age-standardized T2DM prevalence, incidence, mortality, and disability-adjusted life years (DALYs) were analyzed from Global Burden of Diseases (GBD) 2021. Pre-pandemic (2010–2019) and post-pandemic (2020–2021) periods were defined to capture pandemic onset, with 2020–2021 as the earliest available global post-pandemic data. Expected annual percentage changes (EAPC) were derived to assess the magnitude and direction of trends over the study period, adjusting for age, sex, and sociodemographic index. Post-pandemic projections to 2030 employed a Bayesian model with pre-/post-pandemic slope comparisons.Results: Global T2DM prevalence (ages ≥20) rose from 6,887.07 per 100,000 in 2010 to 9,545.42 per 100,000 in 2021. Post-pandemic acceleration was observed: EAPC increased from 2.90% (95% CI: 2.86–2.94) pre-pandemic to 3.52% (95% CI: 3.14–3.90) post-pandemic. Mortality and DALYs showed similar accelerations. Despite continued increases in incidence, mortality, and DALYs, the EAPC decreased in the post-pandemic period. Projections using pre-pandemic data (up to 2019) estimated type 2 diabetes prevalence at 10368.23 per 100,000 population by 2030. However, incorporating post-pandemic data (up to 2021) increased the projected 2030 prevalence to 10694.79 per 100,000, indicating a rise of 326.56 per 100,000 attributed to the pandemic’s impact. The prevalence, incidence, deaths, and DALYs of CKD due to T2DM all showed an upward trend from 2010 to 2021.Conclusions: A rapid increase in the burden of T2DM is found post-COVID-19 pandemic. Enhanced public health interventions are required for the prevention, screening, and management of diabetes.Keywords
This publication has 42 references indexed in Scilit:
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2023
- Diabetes and the COVID-19 pandemicDiabetologia, 2022
- Bidirectional causal associations between type 2 diabetes and COVID‐19Journal of Medical Virology, 2022
- Incidence of newly diagnosed diabetes after Covid-19Diabetologia, 2022
- SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairmentCell Metabolism, 2021
- Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy peoplePrimary Care Diabetes, 2021
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)JAMA, 2020
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 DiabetesCell Metabolism, 2020
- Prevalence of diabetes and cardio‐metabolic risk factors in young men in the United Arab Emirates: A cross‐sectional national surveyEndocrinology, Diabetes & Metabolism, 2019
- Statistical tests, P values, confidence intervals, and power: a guide to misinterpretationsEuropean Journal of Epidemiology, 2016